Cat.#: ACPP-1221
| Despition | Bestrophin Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1513 | Human FGFR2 Protein (AC1513) | 2 µg | inquiry |
| ACPP-1592 | Human CRYAB Protein (AC1592) | 20 µg | inquiry |
| ACPP-1108 | Recombinant Human CD34 Protein (6×His Tag) (AC1108) | 50 µg | inquiry |
| ACPP-1099 | Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) | 10 µg | inquiry |
| ACPP-1350 | Presenilin 2 Blocking Peptide (AC1350) | 250 µg | inquiry |
| ACPP-1833 | Human CRMP1 Protein (AC1833) | 5 µg | inquiry |
| ACPP-1487 | Human Pleiotrophin Protein (AC1487) | 5 µg | inquiry |
| ACPP-1739 | Human SYT3 Protein (AC1739) | 5 µg | inquiry |
| ACPP-1470 | Human CLTA Protein (AC1470) | 5 µg | inquiry |
| ACPP-1848 | Human MTPN Protein (AC1848) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.